New anticoagulantsHIRSH, Jack.The American heart journal. 2001, Vol 142, Num 2, pp S3-S8, issn 0002-8703, SUPConference Paper

Modulating the Coagulation Cascade: New Targets for Antithrombotics and AnticoagulantsHIRSH, Jack.The American heart journal. 2001, Vol 142, Num 2, issn 0002-8703, 32 p., SUPConference Proceedings

Solving the mystery of excessive warfarin-induced bleeding: A personal historical perspectiveHIRSH, Jack.Thrombosis and haemostasis. 2014, Vol 112, Num 5, pp 853-856, issn 0340-6245, 4 p.Article

Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgeryRASKOB, Gary E; HIRSH, Jack.Chest. 2003, Vol 124, Num 6, pp 379S-385S, issn 0012-3692, SUPConference Paper

Recent advances in anticoagulant therapy for acute coronary syndromesTOPOL, Eric.The American heart journal. 2001, Vol 142, Num 2, pp S22-S29, issn 0002-8703, SUPConference Paper

Venous thromboembolism after long flights: are airlines to blame?HIRSH, Jack; O'DONNELL, Martin J.Lancet (British edition). 2001, Vol 357, Num 9267, pp 1461-1462, issn 0140-6736Article

Comparative benefits of clopidogrel and aspirin in high-risk patient populations: Lessons from the CAPRIE and CURE studiesHIRSH, Jack; BHATT, Deepak L.Archives of internal medicine (1960). 2004, Vol 164, Num 19, pp 2106-2110, issn 0003-9926, 5 p.Article

Contemporary Issues in Deep Vein Thrombosis Prophylaxis: A Review of Old, New, and Innovative AgentsHIRSH, Jack.Chest. 2003, Vol 124, Num 6, issn 0012-3692, 51 p., SUPConference Proceedings

New anticoagulant drugsWEITZ, Jeffrey I; HIRSH, Jack.Chest. 2001, Vol 119, Num 1, pp 95S-107S, issn 0012-3692, SUPArticle

Monitoring unfractionated heparin with the aPTT : Time for a fresh look : Laboratory methods in the haemostatic laboratoryEIKELBOOM, John W; HIRSH, Jack.Thrombosis and haemostasis. 2006, Vol 96, Num 5, pp 547-552, issn 0340-6245, 6 p.Article

ACCP conference on antithrombotic therapy, June 21, 1988DALEN, James E; HIRSH, Jack.Chest. 1989, Vol 95, Num 2, issn 0012-3692, A-D, 1S-168S [173 p.]Conference Proceedings

Clinical trials that have influenced the treatment of venous thromboembolism : A historical perspectiveHIRSH, Jack; BATES, Shannon M.Annals of internal medicine. 2001, Vol 134, Num 5, pp 409-417, issn 0003-4819Article

New data in treatment of acute coronary syndromesVAN DE WER, Frans.The American heart journal. 2001, Vol 142, Num 2, pp S16-S21, issn 0002-8703, SUPConference Paper

Bleeding and management of bleedingEIKELBOOM, John W; HIRSH, Jack.European heart journal supplements. 2006, Vol 8G, issn 1520-765X, G38-G45Article

Suboptimal monitoring and dosing of unfractionated heparin in comparative studies with low-molecular-weight heparinRASCHKE, Robert; HIRSH, Jack; GUIDRY, James R et al.Annals of internal medicine. 2003, Vol 138, Num 9, pp 720-723, issn 0003-4819, 4 p.Article

Beyond unfractionated heparin and warfarin : Current and future advancesHIRSH, Jack; O'DONNELL, Martin; EIKELBOOM, John W et al.Circulation (New York, N.Y.). 2007, Vol 116, Num 5, pp 552-560, issn 0009-7322, 9 p.Article

New pentasaccharides for prophylaxis of deep vein thrombosis: PharmacologyBAUER, Kenneth A.Chest. 2003, Vol 124, Num 6, pp 364S-370S, issn 0012-3692, SUPConference Paper

Duration of venous thromboembolism prophylaxis after surgeryKEARON, Clive.Chest. 2003, Vol 124, Num 6, pp 386S-392S, issn 0012-3692, SUPConference Paper

How we diagnose and treat deep vein thrombosisHIRSH, Jack; LEE, Agnes Y. Y.Blood. 2002, Vol 99, Num 9, pp 3102-3110, issn 0006-4971Article

Is impaired renal function a contraindication to the use of low-molecular-weight heparin?NAGGE, Jeff; CROWTHER, Mark; HIRSH, Jack et al.Archives of internal medicine (1960). 2002, Vol 162, Num 22, pp 2605-2609, issn 0003-9926, 5 p.Article

Use of antithrombotic agents during pregnancyGINSBERG, Jeffrey S; GREER, Ian; HIRSH, Jack et al.Chest. 2001, Vol 119, Num 1, pp 122S-131S, issn 0012-3692, SUPArticle

ACCP Concensus Conference on Antithrombotic TherapyDALEN, James E; HIRSH, Jack.Chest. 1998, Vol 114, Num 5, issn 0012-3692, 335 p., SUPConference Proceedings

New Antithrombotic Drugs : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)WEITZ, Jeffrey I; HIRSH, Jack; SAMAMA, Meyer M et al.Chest. 2008, Vol 133, Num 6, issn 0012-3692, 234.S-256.S, SUPArticle

Antiplatelet Drugs : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)PATRONO, Carlo; BAIGENT, Colin; HIRSH, Jack et al.Chest. 2008, Vol 133, Num 6, issn 0012-3692, 199.S-233.S, SUPArticle

Developing a novel antithrombotic in the academic environmentHIRSH, Jack.Seminars in hematology. 2001, Vol 38, Num 2, pp 4-11, issn 0037-1963, SUP5Conference Paper